Mutations in these regions of so-called "junk" DNA are increasingly being linked to a range of diseases, from Crohn's to cancer.
Ever since the Human Genome Project was declared complete in 2003, scientists have sought to pinpoint new regions among the three billion letters of our genetic code which may play a critical role in disease.
With the help of technologies which can analyse whole genome samples faster and more cheaply than ever before, vast numbers of genome-wide association studies dubbed GWAS have been published, identifying genetic variants linked to different chronic illnesses.
Frustratingly for many geneticists, this has turned out to be the easy bit. The much harder part is understanding how they are relevant. For example, while GWAS have identified segments of DNA associated with inflammatory bowel disease at 215 different chromosomal sites , scientists have only been able to pinpoint the exact mechanisms involved for four of them.
One of the biggest challenges is that many of these pieces of DNA lie in so-called gene deserts, swathes of the genome that initially appeared to contain nothing of relevance genetic "junk" that could be disregarded. After all, less than 2% percent of the human genome is dedicated to coding for genes which produce proteins, while much of the remaining 98% has no obvious meaning or purpose.
"You'll go, 'Oh here's a really important association and it increases your risk of many different diseases'," says James Lee, a clinician-scientist who runs a research group at the Francis Crick Institute in London. "But when you actually go and look at that bit of DNA, there's just nothing there."
For many years, gene deserts have been one of the most perplexing areas of medical science, but scientists are slowly managing to accrue information about their apparent purpose and why they exist.
Recently, Lee and colleagues at the Crick Institute published a new investigation into a particular gene desert known as chr21q22. Geneticists have known about this gene desert for more than a decade, because it is associated with at least five different inflammatory diseases from inflammatory bowel disease (IBD) to a form of spinal arthritis known as ankylosing spondylitis. Yet deciphering its function has always proven elusive.
However, for the first time, the Crick scientists were able to show that chr21q22 contains an enhancer, a segment of DNA which can regulate nearby or distant genes, capable of cranking up the amount of proteins they make. Lee refers to this behaviour as "a volume dial". Delving deeper, they found that this enhancer is only active in white blood cells called macrophages where it can ramp up the activity of a previously little-known gene called ETS2.
While macrophages play a vital role in clearing dead cells or fighting off harmful micro-organisms, when the body produces too many they can wreak havoc in inflammatory or autoimmune diseases, flooding into affected tissues and secreting damaging chemicals which attack them. The new study demonstrated that when ETS2 is boosted in macrophages, it heightens virtually all their inflammatory functions.
Lee describes it as "the central orchestrator of inflammation". "We've known for a while that there must be something at the top of the pyramid that is telling the macrophages to behave like this," he says. "But we've never known what it was. The most exciting bit of this, is if we can target it in some way, we might have a new way to treat these diseases."
But if gene deserts are capable of causing us so much harm, why are they in our DNA?
Tracing back in time, Lee's colleagues at the Crick's Ancient Genomics Laboratory were able to show that the disease-causing mutation in chr21q22 first entered the human genome somewhere between 500,000 and one million years ago. This particular DNA change is so ancient that it was even present in the genomes of Neanderthals as well as some ancestors of Homo sapiens.
It turns out that its original purpose was to help the body fight off foreign pathogens. After all, before antibiotics were invented, being able to rapidly switch on a heightened inflammatory response through ETS2 was extremely useful. "Within the first couple of hours of seeing bacteria, it ramps up your macrophage responses," says Lee.
As a result, blocking ETS2 completely could leave IBD patients vulnerable to future infections. However, Lee says when its activity is turned down by between 25 to 50%, it seems to be capable of eliciting a profound anti-inflammatory effect, without risking making the patient too immunosuppressed. While this theory has yet to be tested in clinical trials, the researchers showed that MEK inhibitors a class of cancer drugs which can dampen ETS2 signalling were capable of reducing inflammation not just in macrophages but in gut samples taken from people with IBD.
This appears to represent a new pathway to a completely novel class of treatments for IBD patients. "Some of these MEK inhibitor drugs do have side effects, and what we're trying to do now is to make them more targeted and safer, so that for lifelong diseases like IBD, we would actually be able to offer patients a drug that could switch off the inflammatory process and actually make them a lot better," says Lee.
Now the Crick's researchers are turning their attention to the other four diseases which have been linked to the chr21q22 gene desert, to see whether altering ETS2 activity can also help alleviate the excess inflammation which seems to be driving the condition.
"One of the most significant ones is an inflammatory liver disease called primary sclerosing cholangitis," says Lee. "It's a particularly nasty disease because it can cause liver failure leaving people needing transplants. It can also have a much higher risk of causing liver cancers, and this can happen in young people. And at the moment, there's not a single drug that has been shown to work, there's very little to offer patients," he says.
Scientists also predict that studying gene deserts will yield vital information which will help to improve our understanding of the variouspathways involved in tumour development.
As an example, cancer researchers havepinpointed a gene desert called 8q24.21 which is known to contribute to cervical cancer as the human papilloma virus, the main cause of the disease, embeds itself in this part of the genome. In doing so, the virus enhances a gene called Myc which is a well-known driver of cancer. Studies are suggesting that the connection between 8q24.21 and Myc may also play a role in a number of ovarian, breast, prostate and colorectal cancers.
RichardHoulston, of the Institute of Cancer Research in London, says that various genetic variants which have been identified as contributing to the heritable risk of many common cancers have been found in gene deserts. Knowledge of these target genes will provide opportunities for drug discovery as well as for cancer prevention.
HoweverHoulstonpoints out it is harder to translate this knowledge into new therapeutics for cancer compared to IBD, because tumours are not static targets, but continuously evolve over time. "This is the challenge, whereas with something like Crohn's disease and other bowel conditions, it's not evolving," he says.
Lee is optimistic that the Crick's work on IBD will provide a template for how researchers can find new ways of understanding the pathways involved in all kinds of autoimmune and inflammatory diseases. The institute's scientists are now investigating other gene deserts which have been associated with conditions such as lupus, a disease in which the immune system damages the body's tissues, leading to symptoms such as skin rashes and tiredness.
Other research centres around the world such as the University of Basel in Switzerland are also examining how single inherited mutations in gene deserts could lead to some rare genetic diseases. Three years ago, Basel scientists discovered how one of these mutations could lead to babies being born with limb malformation due to its regulatory effects on a nearby gene.
Lee predicts that understanding the roles of gene deserts will ultimately help improve the notoriously inefficient drug development process. "Making new drugs for these diseases is terribly unsuccessful," he says. "Only about 10% of the drugs going into clinical studies are ever approved at the end, so 90% of them fail because they don't make people better. But if you know that your drug going into development is actually targeting a pathway supported by genetics, the chances of that drug actually being approved is at least somewhere between three- and five-fold higher."
Go here to see the original:
The 'gene deserts' unravelling the mysteries of disease - BBC.com
- Genetics colloquium: Chris Hittinger on the genomic making of metabolic niche breadth Sep. 11 - University of WisconsinMadison - September 15th, 2024 [September 15th, 2024]
- NIH Recognizes Yales Expertise in the Genetics of Rare Diseases - Yale School of Medicine - September 15th, 2024 [September 15th, 2024]
- SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing - PR Newswire - September 15th, 2024 [September 15th, 2024]
- Medicines race dilemma: What science says about genetics and health [PODCAST] - Kevin MD - September 15th, 2024 [September 15th, 2024]
- Researchers want to unlock genetics of the worlds tiniest animals - Popular Science - September 15th, 2024 [September 15th, 2024]
- Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout - Medical Device Network - September 15th, 2024 [September 15th, 2024]
- From farm to future: Technology in genetics - National Hog Farmer - September 2nd, 2024 [September 2nd, 2024]
- Editorial: Plant biotechnology and genetics for sustainable agriculture and global food security - Frontiers - September 2nd, 2024 [September 2nd, 2024]
- NSF Grant Brings Genetics Opportunities to Students in Alabama - Government Technology - September 2nd, 2024 [September 2nd, 2024]
- SBUs Ben Luft brings Lyme expertise to seminal paper on bacterial genetics and evolution - TBR News Media - September 2nd, 2024 [September 2nd, 2024]
- SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference - PR Newswire - September 2nd, 2024 [September 2nd, 2024]
- Singapores National Precision Medicine (NPM) Programme Engages Oxford Nanopore to Advance Understanding of the Genetics of Singapores Multi-Ethnic... - August 5th, 2024 [August 5th, 2024]
- Fulgent Genetics Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - August 5th, 2024 [August 5th, 2024]
- Stopped clinical trials give evidence for the value of genetics - Nature.com - August 5th, 2024 [August 5th, 2024]
- What is DSD? Sex genetics and Olympic boxing controversy - Washington Examiner - August 5th, 2024 [August 5th, 2024]
- Fulgent Genetics Q2: Core Revenue Grows, but Profitability Is Still an Issue - The Motley Fool - August 5th, 2024 [August 5th, 2024]
- Viewpoint: Challenging yet another scientifically silly article claiming Black domination of sprinting and long distance running has nothing to do... - August 5th, 2024 [August 5th, 2024]
- Texas Company Trying To Resurrect Woolly Mammoths To Improve Genetics Of Bison - Cowboy State Daily - August 5th, 2024 [August 5th, 2024]
- Genetics confirms Berbers reached North Africa over 20,000 years ago; Arabs came in 7th Century CE - Down To Earth Magazine - August 5th, 2024 [August 5th, 2024]
- Unlocking plant genetics with telomere-to-telomere genome assemblies - Nature.com - July 26th, 2024 [July 26th, 2024]
- Carlo Ancelotti claims Jude Bellingham's 'genetics' are main reason behind Real Madrid & England superstar's meteoric rise to the top - Goal.com - July 26th, 2024 [July 26th, 2024]
- Genetics-based modeling estimates Idaho's wolf population was 1,150 in summer 2023 - Idaho Fish and Game - July 26th, 2024 [July 26th, 2024]
- Lung Cancer Research Foundation Joins Lung Cancer Advocacy Organizations and 23andMe to Launch Lung Cancer Genetics Study to Advance Research - PR... - July 26th, 2024 [July 26th, 2024]
- Fulgent Genetics (FLGT) Scheduled to Post Earnings on Friday - Defense World - July 26th, 2024 [July 26th, 2024]
- SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix - Financial Times - July 26th, 2024 [July 26th, 2024]
- LG Household & Health Care publishes research into the genetics of skin tone - GlobalCosmeticsNews - July 26th, 2024 [July 26th, 2024]
- Estonians gave their DNA to science now they're learning their genetic secrets - Nature.com - June 27th, 2024 [June 27th, 2024]
- Genetic clues to depression revealed in large study - PsyPost - June 27th, 2024 [June 27th, 2024]
- Move Over, Genghis Khan. Many Other Men Left Huge Genetic Legacies - Smithsonian Magazine - June 27th, 2024 [June 27th, 2024]
- 3X4 Genetics Selected as Partner for Preeminent Cancer Research and Treatment Nonprofit, The Metabolic Terrain ... - BioSpace - June 27th, 2024 [June 27th, 2024]
- NIFA Invests $6M in Animal Breeding, Genetics and Genomics | NIFA - National Institute of Food and Agriculture - June 27th, 2024 [June 27th, 2024]
- Arbel Harpak: Pursuing the Next Frontier in Genetics | Dell Medical School - Dell Medical School - June 27th, 2024 [June 27th, 2024]
- Coffee habits are partly linked to genetics, UC San Diego researchers say - NBC San Diego - June 27th, 2024 [June 27th, 2024]
- Advanced genetic tools help researchers ID new neurodevelopmental syndrome - Yale News - June 27th, 2024 [June 27th, 2024]
- Nutritious diet may protect against type 2 diabetes, regardless of genetics - News-Medical.Net - June 27th, 2024 [June 27th, 2024]
- Genome-wide association study identifies host genetic variants influencing oral microbiota diversity and metabolic ... - Nature.com - June 27th, 2024 [June 27th, 2024]
- Unlock the Secrets of Your DNA with Advanced Genetic Testing - North Forty News - June 27th, 2024 [June 27th, 2024]
- Modern and precise: Using gene editing to change the blueprint of an organism - Beef Magazine - June 27th, 2024 [June 27th, 2024]
- UGA plant geneticists are tackling the climate crisis - Longview News-Journal - June 27th, 2024 [June 27th, 2024]
- Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA - TCTMD - June 27th, 2024 [June 27th, 2024]
- Bringing Gene Therapy to the Brain - The Scientist - June 27th, 2024 [June 27th, 2024]
- The importance of the paradise fish in evolutionary and behavioral genetics research - Phys.org - June 9th, 2024 [June 9th, 2024]
- What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing? - Yahoo Finance - June 9th, 2024 [June 9th, 2024]
- UW initiative aims to bring together social sciences and genetics - Wisbusiness.com - June 9th, 2024 [June 9th, 2024]
- Women have a higher genetic risk for PTSD, according to study by VCU and Swedish researchers - VCU News - June 9th, 2024 [June 9th, 2024]
- Genetics study points to potential treatments for restless leg syndrome - University of Cambridge news - June 9th, 2024 [June 9th, 2024]
- deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans - PR Newswire - June 9th, 2024 [June 9th, 2024]
- Genetic association mapping leveraging Gaussian processes | Journal of Human Genetics - Nature.com - June 9th, 2024 [June 9th, 2024]
- Minimally destructive hDNA extraction method for retrospective genetics of pinned historical Lepidoptera specimens ... - Nature.com - June 9th, 2024 [June 9th, 2024]
- Restless legs syndrome tied to 140 'hotspots' in the genome - Livescience.com - June 9th, 2024 [June 9th, 2024]
- Paired tumor-germline testing can enhance patient carewith guidance from genetics specialists - The Cancer Letter - June 9th, 2024 [June 9th, 2024]
- Improved functional mapping of complex trait heritability with GSA-MiXeR implicates biologically specific gene sets - Nature.com - June 9th, 2024 [June 9th, 2024]
- Genetic Risk Score Revolutionizes TNBC Prediction in Black Women - Targeted Oncology - June 9th, 2024 [June 9th, 2024]
- Gene variants and breast cancer risk in Black women - National Institutes of Health (NIH) (.gov) - June 9th, 2024 [June 9th, 2024]
- GSA-MiXeR: A powerful tool to improve our understanding of heritable traits and diseases - News-Medical.Net - June 9th, 2024 [June 9th, 2024]
- Understanding the effect genetics have on Alzheimer's - Buffalo News - June 9th, 2024 [June 9th, 2024]
- 'Fossil viruses' embedded in the human genome linked to psychiatric disorders - Livescience.com - June 9th, 2024 [June 9th, 2024]
- Louisiana Sports Hall of Fame Profile: Ardoin's genetics provided gift for writing, and his versatility made him legendary - crescentcitysports.com - June 9th, 2024 [June 9th, 2024]
- Genes Link Sleep Patterns to Autism and Bipolar Disorder - Neuroscience News - June 9th, 2024 [June 9th, 2024]
- Tilapia genetics: a comparative trial between two strains in Brazil - The Fish Site - June 1st, 2024 [June 1st, 2024]
- New genetic cause of intellectual disability potentially uncovered in 'junk DNA' - Livescience.com - June 1st, 2024 [June 1st, 2024]
- Scientists identify gene that could lead to resilient 'pixie' corn - College of Agriculture and Life Sciences - June 1st, 2024 [June 1st, 2024]
- Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human ... - PR Newswire - June 1st, 2024 [June 1st, 2024]
- Alzheimer's study suggests genetic cause of specific form of disease Harvard Gazette - Harvard Gazette - June 1st, 2024 [June 1st, 2024]
- Researchers Discover Genetic Underpinnings of Inherited Condition Often Misdiagnosed as Hypothyroidism - InventUM - University of Miami - June 1st, 2024 [June 1st, 2024]
- Too much or too little: The impact of protein dosage on development - EurekAlert - June 1st, 2024 [June 1st, 2024]
- Hussman Institute Celebrates National DNA Day with Frost Science Museum - InventUM - University of Miami - June 1st, 2024 [June 1st, 2024]
- International treaty agreed on handling genetics in patents - Research Professional News - June 1st, 2024 [June 1st, 2024]
- Nebraska team identifies new genetic defect impacting cattle morbidity and meat quality - Beef Magazine - June 1st, 2024 [June 1st, 2024]
- Exploring the wonders of molecular biology - Drug Target Review - June 1st, 2024 [June 1st, 2024]
- 30 Years After Genetic Discovery, Huntingtons Patients Still Waiting - BioSpace - June 1st, 2024 [June 1st, 2024]
- Arn Anderson Bron Breakker Has Got His Dads Genetics, Will Be A Big Star - eWrestlingNews - June 1st, 2024 [June 1st, 2024]
- Genetic research: possibilities and risks Exaudi - Exaudi - June 1st, 2024 [June 1st, 2024]
- Study shows effect of 'interaction' on epigenetic marking in... - Parkinson's News Today - June 1st, 2024 [June 1st, 2024]
- The same genetic mutations behind gorillas' small penises may hinder fertility in men - Livescience.com - May 24th, 2024 [May 24th, 2024]
- Genetics reveals surprising origin of the German cockroach - Cosmos - May 24th, 2024 [May 24th, 2024]
- Genetics Reveals The Mysterious Origins Of The Cockroach - Forbes - May 24th, 2024 [May 24th, 2024]
- Optimizing genetics to advance controlled environment agriculture - AgriLife Today - AgriLife Today - May 24th, 2024 [May 24th, 2024]
- Genetics help combat illegal movement of feral swine - The Wildlife Society - May 24th, 2024 [May 24th, 2024]
- Tracking the cellular and genetic roots of neuropsychiatric disease - Yale News - May 24th, 2024 [May 24th, 2024]